The Effect of Blue-light Filtering Spectacle Lenses on Myopia Progression in Schoolchildren

NCT ID: NCT03538002

Last Updated: 2022-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

148 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-10

Study Completion Date

2021-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate if the blue-light filtering spectacle lenses promote myopia progression in schoolchildren.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The effect of blue light on ocular health has been studied extensively. Shorter wavelength such as blue light could cause damage to the retina. The damage was more evident in the ageing eye. Since the tablets and mobile with blue LED backlight display are widely used, thus blue-light filtering spectacle lenses are now available in the market. However, whether this kind of lenses could affect the eye growth in schoolchildren is unknown. This study is then designed to investigate if the blue-light filtering spectacle lenses affect myopia progression in Hong Kong Chinese schoolchildren. The schoolchildren will be randomly allocated to either blue-light filtering spectacle lens group (treated) or conventional spectacle lens group (control). Their axial length and refraction will be monitored every 6 months for 2 years. The changes between two group will then be compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional anti-reflection coated spectacle lens

Single vision lenses with correction of distant refraction and conventional anti-reflection coating

Group Type NO_INTERVENTION

No interventions assigned to this group

Blue-light filtering spectacle lenses

Single vision lenses with correction of distant refraction and blue-light filtering coating

Group Type EXPERIMENTAL

Blue-light filtering spectacle lenses

Intervention Type DEVICE

This is a single vision spectacle lens for correction of distant refractions and filtering out the blue light by providing anti-blue light coating.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blue-light filtering spectacle lenses

This is a single vision spectacle lens for correction of distant refractions and filtering out the blue light by providing anti-blue light coating.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Refraction: myopia of -1.00 dioptres (D) to -5.00D
* Astigmatism: equal or less than -1.50D
* Anisometropia: equal or less than 1.00D
* Best corrected monocular visual acuity: 0.0 LogMAR or better after full correction
* Parents' understanding and acceptance of random allocation of grouping

Exclusion Criteria

* any ocular and systemic abnormalities might affect visual functions or refractive development
* prior treatment of myopic control, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, drugs (e.g. atropine), etc.
Minimum Eligible Age

8 Years

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Hong Kong Polytechnic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ka Man Chun, PhD

Role: PRINCIPAL_INVESTIGATOR

Centre for Myopia Research, The Hong Kong Polytechnic University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre of Myopia Research, School of Optometry, The Hong Kong Polytechnic University

Hong Kong, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

05161146

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Myopia Prevention With Reading Glasses
NCT05030103 NOT_YET_RECRUITING NA